Omeros Corp. (OMER) Announces Presentation of Additional OMS302 Clinical Data at the Annual ASCRS and ASOA Symposium and Congress
Friday, clinical-stage biopharmaceutical company Omeros announced it will present additional data from recent clinical trials of OMS302, its ophthalmology project,…